Clinical Trial Update: ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 5-aminolevulinic acid–based photodynamic therapy (ALA-PDT) in CIN2 patients who are p16-positive and HPV high-risk positive; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Papillomavirus Infections

Drugs mentioned

• 5-aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: Cervical Intraepithelial Neoplasia Grade 2, Papillomavirus Infections | Phase 2 | Status: COMPLETED